Bone mineral density as a prognostic marker in patients with non-small cell lung cancer undergoing neoadjuvant chemoimmunotherapy
Fengyi Zhou, Peile Li, Jian Peng Zou, Weixuan Lei, Wei Han, Yun Gu, Yan Ling Hu, Chao Zeng 等 17 位
Second Xiangya Hospital of Central South University Army Medical University Daping Hospital Central South University
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
BACKGROUND: Non-small cell lung cancer (NSCLC) is the most common lung cancer, and surgery is the primary curative treatment approach. Recently, neoadjuvant immunotherapy combined with chemotherapy (NICT) has become an important strategy. However, not all patients benefit, underscoring the need for reliable prognostic biomarkers. Bone mineral density (BMD) is associated with the prognosis of various cancers. This study explores the relationship between computed tomography (CT)-derived BMD and prognosis in NSCLC patients treated with NICT. METHODS: 101 stage IIA-IIIB NSCLC patients undergoing NICT and R0 resection surgery at our institution were included. Chest CT, highly correlated with dual-energy X-ray absorptiometry (DXA), was used to analyze the baseline and preoperative T10, T12, and L1 BMD. We analyzed disease-free survival (DFS) and overall survival (OS) through Kaplan-Meier survival curves, cox regression, and restricted cubic splines (RCS). Major pathologic response (MPR) and pathologic complete response (pCR) were compared through logistic regression. Subgroup analysis and sensitivity analysis were conducted to evaluate the accuracy of the results. RESULTS: Median DFS was 22.58 months, and 14 patients experienced tumor recurrence or death. A significant decrease in BMD was observed at the T10, T12, and L1 vertebrae following NICT (p < 0.001). Patients with higher baseline and preoperative L1 BMD had significantly improved DFS (p = 0.002, p = 0.002). The prognostic value for BMD was confirmed through RCS analysis and multivariate Cox-regression analysis, as well as sensitivity analysis. Subgroup analysis revealed that the effect of L1 BMD on DFS showed significant interaction in age and MPR groups, suggesting age specific and treatment-response specific differences. CONCLUSION: Both baseline and preoperative L1 BMD are valuable, readily available, and independent prognostic biomarkers for DFS in NSCLC patients receiving NICT.
逐年被引趋势
暂无年度引用数据
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Lung Cancer Diagnosis and Treatment
Lung Cancer Research Studies · Bone health and osteoporosis research
参考文献 39
此处列出前 3 条